![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
OPTIC: ponatinib in resistant chronic-phase CML (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View |
![]() |
Ponatinib in chronic-phase CML patients with prior second generation TKI exposure (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View |
![]() |
Is Ponatinib Safe for Treating CML (CheckRare) View |
![]() |
OPTIC: A dose-ranging study of 3 starting doses of ponatinib for chronic-phase chronic myeloid l... (ecancer) View |
![]() |
Jorge E Cortes ASCO20: Interim Analysis of the Phase II OPTIC Trial of Ponatinib in CP-CML (Touch Medical Media) View |
![]() |
Role of Ponatinib in Treatment of R/R CML (Targeted Oncology) View |
![]() |
FDA Approves New Dosing for Ponatinib to Treat Chronic Myeloid Leukemia (CheckRare) View |
![]() |
All you need to know about CML in 4 minutes (Fadi Haddad M.D.) View |
![]() |
Dose-Related Adverse Events With Ponatinib When Treating CML (Targeted Oncology) View |
![]() |
Ponatinib Efficacy and Safety With the T315I Mutation: Long-Term Follow-up of Phase 1u00262 Trials (Oncology.TV) View |